Theralink Technologies Inc THER Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Nov 6
Last close · Previous close $0.00
- 52-week change
- unchangedPrice only
- Distributions
- $0.00Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedPast month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Nov 5
- Volume0.00Nov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.00 to $0.00; now $0.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
THER beat the S&P 500 in 2 of 7 periods.
| Period | THER and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | THER: unchanged S&P 500: down 5.6% | THER beat the S&P 500 by 5.6 percentage points Beat |
| 3M | THER: unchanged S&P 500: down 4.1% | THER beat the S&P 500 by 4.1 percentage points Beat |
| YTD | THER: unchanged S&P 500: up 8.7% | THER trailed the S&P 500 by 8.7 percentage points Trailed |
| 1Y | THER: unchanged S&P 500: up 10.9% | THER trailed the S&P 500 by 10.9 percentage points Trailed |
| Long term | ||
| 3Y | THER: down 99.9% S&P 500: up 75.0% −90.0% vs +20.5% a year | THER trailed the S&P 500 by 174.9 percentage points Trailed |
| 5Y | THER: down 100.0% S&P 500: up 67.8% −94.6% vs +10.9% a year | THER trailed the S&P 500 by 167.8 percentage points Trailed |
| 10Y | THER: down 100.0% S&P 500: up 313.1% −84.4% vs +15.2% a year | THER trailed the S&P 500 by 413.1 percentage points Trailed |
$10,000 invested in THER 10 years ago (Nov 4, 2016) would be worth about $0 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
THER beat the S&P 500 in 2 of 7 periods.
| Period | THER and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | THER: unchanged S&P 500: down 5.6% | THER beat the S&P 500 by 5.6 percentage points Beat |
| 3M | THER: unchanged S&P 500: down 4.3% | THER beat the S&P 500 by 4.3 percentage points Beat |
| YTD | THER: unchanged S&P 500: up 7.8% | THER trailed the S&P 500 by 7.8 percentage points Trailed |
| 1Y | THER: unchanged S&P 500: up 9.7% | THER trailed the S&P 500 by 9.7 percentage points Trailed |
| Long term | ||
| 3Y | THER: down 99.9% S&P 500: up 68.8% −90.0% vs +19.1% a year | THER trailed the S&P 500 by 168.7 percentage points Trailed |
| 5Y | THER: down 100.0% S&P 500: up 56.9% −94.6% vs +9.4% a year | THER trailed the S&P 500 by 156.9 percentage points Trailed |
| 10Y | THER: down 100.0% S&P 500: up 252.6% −84.4% vs +13.4% a year | THER trailed the S&P 500 by 352.6 percentage points Trailed |
$10,000 invested in THER 10 years ago (Nov 4, 2016) would be worth about $0 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$6,142.50
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Jul 30, 2010.
Stock splits
1
1-for-750 on . Share counts adjust after each split.
About Theralink Technologies Inc
Theralink Technologies is a proteomics-based, precision medicine company with a CLIA-certified and CAP-accredited laboratory located in Golden, Colorado. Through its unique and patented phosphoprotein and protein biomarker platform and LDTs, Theralink's technology targets multiple areas of oncology and drug development. In addition to the Company's first assay for advanced breast cancer, Theralink is actively working on a second assay that is planned to be pan-tumor for solid tumors across multiple tumor types such as ovarian, endometrial, pancreatic, liver, head and neck, colorectal, lung, prostate, among others. Theralink provides precision oncology data through its powerful Theralink ® Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. Theralink intends to help improve cancer outcomes for patients, help reveal therapeutic options for oncologists, and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
THER news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
THER stock FAQ
What is THER stock’s price today?
Theralink Technologies (THER) traded at $0.00 at the close on , unchanged from the previous close of $0.00. Over the past 52 weeks it has traded between $0.00 and $0.00.
If you invested $1,000 in THER 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in THER on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $0 if invested five years ago and $1,000 if invested one year ago. Past performance doesn’t predict future returns.
What is Theralink Technologies’s market cap?
Theralink Technologies’s market capitalization is about $0.0 thousand. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.00 (how market cap works).
Does THER pay a dividend?
Theralink Technologies hasn’t paid a dividend in the last twelve months.
What is THER’s 52-week high and low?
Over the past 52 weeks THER has traded as low as $0.00 and as high as $0.00. At $0.00 at the close on , it is 99.0% below that high and 0.0% above the low.
What is THER’s all-time high?
THER’s highest closing price was $6,142.50 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has THER stock ever split?
Yes, once: 1-for-750 on .
How has THER stock performed?
Including dividends and measured to the close on , THER has returned 0.0% so far this year and 0.0% over the past year, and −100.0% over five years (−94.6% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Theralink Technologies in?
Theralink Technologies is in the Healthcare sector and the Medical Devices industry, and is headquartered in California, USA.
What exchange does THER trade on?
Theralink Technologies trades on the PINK under the ticker symbol THER. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.